Urogenital Microbiota:Potentially Important Determinant of PD-L1 Expression in Male Patients with Non-muscle Invasive Bladder Cancer

被引:29
作者
Chen, Chunxiao [1 ]
Huang, Zehai [1 ]
Huang, Pengcheng [1 ]
Li, Kun [2 ]
Zeng, Jiarong [3 ]
Wen, Yuehui [4 ]
Li, Biao [1 ]
Zhao, Jie [5 ]
Wu, Peng [1 ,6 ]
机构
[1] Southern Med Univ, Nanfang Hosp, Dept Urol, Guangzhou, Peoples R China
[2] Third Hosp Mianyang, Mianyang, Sichuan, Peoples R China
[3] Meizhou Peoples Hosp, Dept Urol, Meizhou, Peoples R China
[4] Meizhou Hosp TCM, Meizhou, Peoples R China
[5] Southern Med Univ, Sch Pharmaceut Sci, Guangzhou, Peoples R China
[6] Southern Med Univ, Nanfang Hosp, Clin Microbiota Ctr, Guangzhou, Peoples R China
基金
中国国家自然科学基金;
关键词
Bladder cancer; Urogenital tract; Microbiota; PD-L1; Immune escape; RNA GENE DATABASE; MICROBIOME; CELLS; CARCINOMA; B7-H1; INFLAMMATION; ASSOCIATION; SEQUENCES;
D O I
10.1186/s12866-021-02407-8
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Background Urogenital microbiota may be associated with the recurrence of bladder cancer, but the underlying mechanism remains unclear. The notion that microbiota can upregulate PD-L1 expression in certain epithelial tumors to promote immune escape has been demonstrated. Thus, we hypothesized that the urogenital microbiota may be involved in the recurrence and progression of non-muscle invasive bladder cancer (NMIBC) by upregulating the PD-L1 expression. To test this hypothesis, we investigated the relationship between urogenital microbial community and PD-L1 expression in male patients with NMIBC. Results 16S rRNA gene sequencing was performed to analyse the composition of urogenital microbiota, and the expression of PD-L1 in cancerous tissues was detected by immunohistochemistry. The subjects (aged 43-79 years) were divided into PD-L1-positive group (Group P, n = 9) and PD-L1-negative group (Group N, n = 19) respectively based on their PD-L1 immunohistochemical results. No statistically significant differences were found in the demographic characteristics between group P and N. We observed that group P exhibited higher species richness (based on Observed species and Ace index, both P < 0.05). Furthermore, subgroup analysis showed that the increase in number of PD-L1 positive cells was accompanied by increased richness of urogenital microbiota. Significantly different composition of urogenital microbiota was found between group P and group N (based on weighted Unifrac and unweighted Unifrac distances metric, both P < 0.05). Enrichment of some bacterial genera (e.g., Leptotrichia, Roseomonas, and Propionibacterium) and decrease of some bacterial genera (e.g., Prevotella and Massilia) were observed in group P as compared with group N. These findings indicated that these genera may affect the expression of PD-L1 through some mechanisms to be studied. Conclusion Our study provided for the first time an overview of the association between urogenital microbiota and PD-L1 expression in male patients with NMIBC, indicating that urogenital microbiota was an important determinant of PD-L1 expression in male NMIBC patients.
引用
收藏
页数:12
相关论文
共 59 条
[1]   European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ)-2019 Update [J].
Babjuk, Marko ;
Burger, Maximilian ;
Comperat, Eva M. ;
Gontero, Paolo ;
Mostafid, A. Hugh ;
Palou, Joan ;
van Rhijn, Bas W. G. ;
Roupret, Morgan ;
Shariat, Shahrokh F. ;
Sylvester, Richard ;
Zigeuner, Richard ;
Capoun, Otakar ;
Cohen, Daniel ;
Dominguez Escrig, Jose Luis ;
Hernandez, Virginia ;
Peyronnet, Benoit ;
Seisen, Thomas ;
Soukup, Viktor .
EUROPEAN UROLOGY, 2019, 76 (05) :639-657
[2]   Urinary microbiota - a potential biomarker and therapeutic target for bladder cancer [J].
Bi, Hai ;
Tian, Ya ;
Song, Chuan ;
Li, Jiarui ;
Liu, Tingting ;
Chen, Zhen ;
Chen, Chen ;
Huang, Yi ;
Zhang, Yuanyuan .
JOURNAL OF MEDICAL MICROBIOLOGY, 2019, 68 (10) :1471-1478
[3]   Interaction of PD-L1 on tumor cells with PD-1 on tumor-specific T cells as a mechanism of immune evasion: implications for tumor immunotherapy [J].
Blank, C ;
Gajewski, TF ;
Mackensen, A .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2005, 54 (04) :307-314
[4]  
Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI [10.3322/caac.21492, 10.3322/caac.21609]
[5]   Forming Consensus To Advance Urobiome Research [J].
Brubaker, Linda ;
Gourdine, Jean-Philippe F. ;
Siddiqui, Nazema Y. ;
Holland, Amanda ;
Halverson, Thomas ;
Limeria, Roberto ;
Pride, David ;
Ackerman, Lenore ;
Forster, Catherine S. ;
Jacobs, Kristin M. ;
Thomas-White, Krystal J. ;
Putonti, Catherine ;
Dong, Qunfeng ;
Weinstein, Michael ;
Lukacz, Emily S. ;
Karstens, Lisa ;
Wolfe, Alan J. .
MSYSTEMS, 2021, 6 (04)
[6]   Microbiota-driven interleukin-17-producing cells and eosinophils synergize to accelerate multiple myeloma progression [J].
Calcinotto, Arianna ;
Brevi, Arianna ;
Chesi, Marta ;
Ferrarese, Roberto ;
Perez, Laura Garcia ;
Grioni, Matteo ;
Kumar, Shaji ;
Garbitt, Victoria M. ;
Sharik, Meaghen E. ;
Henderson, Kimberly J. ;
Tonon, Giovanni ;
Tomura, Michio ;
Miwa, Yoshihiro ;
Esplugues, Enric ;
Flavell, Richard A. ;
Huber, Samuel ;
Canducci, Filippo ;
Rajkumar, Vincent S. ;
Bergsagel, P. Leif ;
Bellone, Matteo .
NATURE COMMUNICATIONS, 2018, 9
[7]   QIIME allows analysis of high-throughput community sequencing data [J].
Caporaso, J. Gregory ;
Kuczynski, Justin ;
Stombaugh, Jesse ;
Bittinger, Kyle ;
Bushman, Frederic D. ;
Costello, Elizabeth K. ;
Fierer, Noah ;
Pena, Antonio Gonzalez ;
Goodrich, Julia K. ;
Gordon, Jeffrey I. ;
Huttley, Gavin A. ;
Kelley, Scott T. ;
Knights, Dan ;
Koenig, Jeremy E. ;
Ley, Ruth E. ;
Lozupone, Catherine A. ;
McDonald, Daniel ;
Muegge, Brian D. ;
Pirrung, Meg ;
Reeder, Jens ;
Sevinsky, Joel R. ;
Tumbaugh, Peter J. ;
Walters, William A. ;
Widmann, Jeremy ;
Yatsunenko, Tanya ;
Zaneveld, Jesse ;
Knight, Rob .
NATURE METHODS, 2010, 7 (05) :335-336
[8]   Dysbiosis of the microbiome in gastric carcinogenesis [J].
Castano-Rodriguez, Natalia ;
Goh, Khean-Lee ;
Fock, Kwong Ming ;
Mitchell, Hazel M. ;
Kaakoush, Nadeem O. .
SCIENTIFIC REPORTS, 2017, 7
[9]   Mechanisms Controlling PD-L1 Expression in Cancer [J].
Cha, Jong-Ho ;
Chan, Li-Chuan ;
Li, Chia-Wei ;
Hsu, Jennifer L. ;
Hung, Mien-Chie .
MOLECULAR CELL, 2019, 76 (03) :359-370
[10]   IL-6/JAK1 pathway drives PD-L1 Y112 phosphorylation to promote cancer immune evasion [J].
Chan, Li-Chuan ;
Li, Chia-Wei ;
Xia, Weiya ;
Hsu, Jung-Mao ;
Lee, Heng-Huan ;
Cha, Jong-Ho ;
Wang, Hung-Ling ;
Yang, Wen-Hao ;
Yen, Er-Yen ;
Chang, Wei-Chao ;
Zha, Zhengyu ;
Lim, Seung-Oe ;
Lai, Yun-Ju ;
Liu, Chunxiao ;
Liu, Jielin ;
Dong, Qiongzhu ;
Yang, Yi ;
Sun, Linlin ;
Wei, Yongkun ;
Nie, Lei ;
Hsu, Jennifer L. ;
Li, Hui ;
Ye, Qinghai ;
Hassan, Manal M. ;
Amin, Hesham M. ;
Kaseb, Ahmed O. ;
Lin, Xin ;
Wang, Shao-Chun ;
Hung, Mien-Chie .
JOURNAL OF CLINICAL INVESTIGATION, 2019, 129 (08) :3324-3338